Ładuje się......
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy
Treatment with anti‐programmed cell death protein 1 (PD‐1) antibodies has demonstrated clinical efficacy in a whole range of malignancies including advanced melanoma, renal cell cancer, bladder cancer, and non‐small cell lung cancer. Immune‐related adverse events are a unique side effect of checkpoi...
Zapisane w:
| Wydane w: | Oncologist |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
AlphaMed Press
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058335/ https://ncbi.nlm.nih.gov/pubmed/29666298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0531 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|